SMS Pharmaceuticals Ltd.
Fundamentals
- Market cap
- ₹3,526 cr
- P/E
- 34.58×
- ROE
- 10.81%
- Debt / equity
- 0.49
- Div yield
- 0.11%
- 52-week range
- 207.99 — 447.80
Company snapshot
SMS Pharmaceuticals Ltd.
Pharmaceuticals
₹3,910 cr
P/E 38.34×
Latest quarter · Mar 2026
Sales₹238 cr
Net profit₹21 cr
Op. margin+16.8%
EPS₹3.49
Strength & growth
Debt / equity0.49×
Current ratio1.67×
Sales CAGR+3.9%
EPS CAGR+8.2%
The timeline — 5 notes on SMS Pharmaceuticals Ltd.
May 2026
- 27 May 26 · 11:51 AM IST Brief Brief · Concalls · Small cap
SMS Pharmaceuticals cuts FY27 growth target to 15% on geopolitical risk
The company lowered its revenue guidance from 20% while shifting focus toward higher-margin API segments to protect profitability.
- 22 May 26 · 3:20 PM IST Brief Brief · Earnings · Small cap
SMS Pharmaceuticals books ₹87.61 cr annual profit
Annual results confirm steady growth with a final dividend of ₹0.40 per share.
- 22 May 26 · 3:16 PM IST Brief Brief · Earnings · Small cap
SMS Pharmaceuticals hits ₹87.61 cr profit as FY26 growth hits target
Revenue climbed 13% to ₹886.87 cr, matching earlier guidance. The board approved a dividend of ₹0.40 per share.
- 22 May 26 · 1:57 PM IST Brief Brief · Earnings · Small cap
SMS Pharmaceuticals grows FY26 revenue to ₹886.87 cr
The company’s annual results reflect steady growth alongside a final dividend of ₹0.40 per share.
- 22 May 26 · 1:49 PM IST Brief Brief · Earnings · Small cap
SMS Pharma posts 28% profit jump for FY26; dividend is a token ₹0.40
Full-year net profit grew to ₹87.61 crore on 13.3% revenue growth. The market has seen the quarterly build-up already.